{"id":10996,"date":"2025-02-28T14:41:46","date_gmt":"2025-02-28T14:41:46","guid":{"rendered":"https:\/\/cdv.com.ar\/global\/pt?p=10996"},"modified":"2025-05-20T13:10:38","modified_gmt":"2025-05-20T13:10:38","slug":"a-cdv-melhor-empresa-de-sanidade-animal-do-mundo-em-2024","status":"publish","type":"post","link":"https:\/\/cdv.com.ar\/global\/pt\/a-cdv-melhor-empresa-de-sanidade-animal-do-mundo-em-2024\/","title":{"rendered":"A CDV, melhor empresa de sanidade animal do mundo em 2024"},"content":{"rendered":"

[vc_row woodmart_css_id=”67aca7bfb9514″ responsive_spacing=”eyJwYXJhbV90eXBlIjoid29vZG1hcnRfcmVzcG9uc2l2ZV9zcGFjaW5nIiwic2VsZWN0b3JfaWQiOiI2N2FjYTdiZmI5NTE0Iiwic2hvcnRjb2RlIjoidmNfcm93IiwiZGF0YSI6eyJ0YWJsZXQiOnt9LCJtb2JpbGUiOnt9fX0=” mobile_bg_img_hidden=”no” tablet_bg_img_hidden=”no” woodmart_parallax=”0″ woodmart_gradient_switch=”no” woodmart_box_shadow=”no” wd_z_index=”no” woodmart_disable_overflow=”0″ row_reverse_mobile=”0″ row_reverse_tablet=”0″][vc_column width=”1\/2″]\t\t

\n\t\t\t\n\t\t\t\"\"\n\t\t\t\t\t<\/div>\n\t\t[\/vc_column][vc_column width=”1\/2″][vc_column_text css=”” woodmart_inline=”no” text_larger=”no”]A CDV recebeu o pr\u00eamio \u201cAnimal Health Awards\u201d ap\u00f3s um ano marcado por destaques em novos produtos, alian\u00e7as estrat\u00e9gicas, investimentos e crescimento sustent\u00e1vel.<\/span><\/i><\/p>\n

O laborat\u00f3rio <\/span>CDV<\/b> foi distinguido em Londres com o prestigioso pr\u00eamio de Melhor Empresa de Sanidade Animal Mundial, na d\u00e9cima edi\u00e7\u00e3o dos \u201cAnimal Health Awards 2024\u201d.\u00a0 Ele j\u00e1 tinha sido premiado em 2019 e 2023 como l\u00edder em sa\u00fade animal da Am\u00e9rica Latina.<\/span><\/p>\n

Diferente de edi\u00e7\u00f5es anteriores, este ano o pr\u00eamio n\u00e3o foi concedido por regi\u00f5es, mas em escala mundial. Para a empresa, essa conquista reafirma seu compromisso com o bem-estar animal e sua abordagem integral em sustentabilidade e preven\u00e7\u00e3o, alinhada com a filosofia “One Health”.<\/span><\/p>\n

“Este pr\u00eamio n\u00e3o apenas valida nosso trabalho, mas reflete o compromisso de toda a equipe da CDV. <\/span><\/i>Isso nos motiva a continuar inovando e ampliando nossas solu\u00e7\u00f5es para melhorar a qualidade de vida dos animais, aumentar a produtividade dos rebanhos e contribuir para o bem-estar global”, destacou Juan Roo, Gerente Geral do Laborat\u00f3rio CDV.<\/span><\/p>\n

A CDV completou a obra civil da planta mais avan\u00e7ada da ind\u00fastria veterin\u00e1ria, com um investimento de 80 milh\u00f5es de d\u00f3lares. Esta moderna instala\u00e7\u00e3o, que come\u00e7ar\u00e1 a operar em breve, atender\u00e1 as normativas internacionais mais exigentes e triplicar\u00e1 a capacidade produtiva.\u00a0<\/span><\/p>\n

\u00c9 importante salientar que, paralelamente, foi inaugurada uma planta exclusiva para a produ\u00e7\u00e3o de vacinas contra a brucelose e foi estabelecida uma filial de pesquisa e desenvolvimento nos Estados Unidos, com foco em biotecnologia avan\u00e7ada, abrangendo tecnologias como ARN mensageiro e prote\u00ednas recombinantes.\u00a0<\/span><\/p>\n

A empresa continua acelerando sua expans\u00e3o global, consolidando sua presen\u00e7a na Am\u00e9rica Latina, \u00c1sia, \u00c1frica e Europa, alcan\u00e7ando mais de 200 novos registros aprovados no ano passado. <\/span>\u00a0<\/span><\/i>\u201cEste crescimento cont\u00ednuo impulsiona o planejamento de uma quarta planta, com o objetivo de atender \u00e0 crescente demanda por produtos de qualidade em n\u00edvel mundial\u201d, acrescentou Roo.<\/span><\/p>\n

Gra\u00e7as \u00e0 sua alian\u00e7a estrat\u00e9gica com a Genneia, 80% da energia que consome prov\u00e9m de fontes renov\u00e1veis, tornando-se o primeiro laborat\u00f3rio veterin\u00e1rio argentino a alcan\u00e7ar esse significativo feito.\u00a0<\/span><\/p>\n

 <\/p>\n

No campo da inova\u00e7\u00e3o, o laborat\u00f3rio desenvolve vacinas para diversas esp\u00e9cies, incluindo a encefalomielite equina e outras para su\u00ednos e animais de estima\u00e7\u00e3o, alcan\u00e7ando avan\u00e7os significativos em cada uma dessas linhas.\u00a0<\/span><\/p>\n

 <\/p>\n

Em comemora\u00e7\u00e3o ao seu 40\u00ba anivers\u00e1rio em 2025, a empresa prev\u00ea um crescimento de 26% e tem como objetivo se posicionar entre os 20 principais laborat\u00f3rios veterin\u00e1rios do mundo nos pr\u00f3ximos anos.\u00a0<\/span><\/p>\n

 <\/p>\n

A recente conquista refor\u00e7a sua lideran\u00e7a, destacando sua contribui\u00e7\u00e3o para a produtividade pecu\u00e1ria e para um sistema alimentar seguro e sustent\u00e1vel.\u00a0 “Estamos orgulhosos de que este reconhecimento permane\u00e7a na Argentina, refletindo o talento de nosso capital humano, a excel\u00eancia profissional e o desenvolvimento de tecnologia de ponta”, concluiu o executivo da CDV.<\/span><\/p>\n

 <\/p>\n

Ap\u00f3s a obten\u00e7\u00e3o dessa distin\u00e7\u00e3o, a empresa enfatizou a dedicat\u00f3ria a todo seu pessoal, clientes, veterin\u00e1rios, produtores, institui\u00e7\u00f5es e todos aqueles que trabalham por uma melhor produ\u00e7\u00e3o.\u00a0\u00a0<\/span><\/p>\n

 <\/p>\n

Sobre a CDV:<\/strong>
\nA CDV \u00e9 um laborat\u00f3rio argentino l\u00edder, especializado na elabora\u00e7\u00e3o de vacinas para a preven\u00e7\u00e3o de doen\u00e7as que afetam rebanhos bovinos e ovinos, com 40 anos de trajet\u00f3ria na Argentina. Sua linha de produtos e servi\u00e7os voltados para a preven\u00e7\u00e3o \u00e9 a mais completa do mercado, composta por vacinas virais e bacterianas, vacina antiaftosa, reagentes e servi\u00e7o de diagn\u00f3stico. Desde 2002, inova na produ\u00e7\u00e3o de vacinas para a aquicultura. Em 2019 e 2023, a revista brit\u00e2nica Animal Health reconheceu o laborat\u00f3rio CDV como a \u201cMelhor empresa do Setor Veterin\u00e1rio na Am\u00e9rica Latina\u201d. A CDV exporta seus produtos para mais de 20 pa\u00edses.<\/p>\n

Ela conta com duas modernas plantas de produ\u00e7\u00e3o de vacinas e uma terceira em desenvolvimento localizadas no Parque Industrial Pilar, na prov\u00edncia de Buenos Aires:<\/p>\n

Planta 1:<\/strong> desde 2003, produzimos vacinas para a preven\u00e7\u00e3o de doen\u00e7as reprodutivas, respirat\u00f3rias, clostridiais, queratoconjuntivite, complexos ent\u00e9ricos neonatais e preventivos de importantes doen\u00e7as zoon\u00f3ticas como brucelose, raiva, carb\u00fanculo e leptospirose. Tamb\u00e9m elaboramos reagentes de diagn\u00f3stico para a detec\u00e7\u00e3o de tuberculose e brucelose e vacinas para prevenir doen\u00e7as em aves e salmon\u00eddeos. No mesmo local, encontra-se o Laborat\u00f3rio de Diagn\u00f3stico, pertencente \u00e0 rede do SENASA. Ele tem uma capacidade total de produ\u00e7\u00e3o anual de 150 milh\u00f5es de doses: 85 milh\u00f5es de doses para vacinas de bovinos e, o restante, para salmon\u00eddeos e aves.<\/p>\n

Planta 2:<\/strong> produz exclusivamente vacinas contra febre aftosa desde 2018. Esta planta possui equipamentos de \u00faltima gera\u00e7\u00e3o e um alto grau de automa\u00e7\u00e3o de sistemas para garantir o cumprimento dos padr\u00f5es de qualidade e biosseguran\u00e7a mais exigentes em n\u00edvel mundial. A capacidade produtiva \u00e9 de mais de 60 milh\u00f5es de doses de vacina contra febre aftosa.<\/p>\n

Planta 3:<\/strong> atualmente est\u00e1 em constru\u00e7\u00e3o e estima-se que esteja operacional durante o primeiro semestre de 2025. Ampliar\u00e1 a capacidade produtiva da Planta 1 e ser\u00e1 poss\u00edvel fabricar produtos para a sanidade animal e a preven\u00e7\u00e3o de doen\u00e7as em novas esp\u00e9cies: vacinas para animais de estima\u00e7\u00e3o, animais de companhia e su\u00ednos. A capacidade produtiva total projetada alcan\u00e7ar\u00e1, junto com a produ\u00e7\u00e3o da planta 1, 280 milh\u00f5es de doses, das quais 190 milh\u00f5es correspondem a vacinas para bovinos. Acompanhe a obra ao vivo por livestreaming: https:\/\/cdv.com.ar\/live\/<\/a>[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text css=”” woodmart_inline=”no” text_larger=”no”]CDV has completed the civil works of the most advanced plant in the veterinary industry, with an investment of US$80MM. This modern facility, which will be operational soon, will comply with the most demanding international regulations, with a three-fold production capacity increase.<\/p>\n

Note that an exclusive plant for the production of vaccines against brucellosis was simultaneously inaugurated, in tandem with a research and development subsidiary in the United States, focused on advanced biotechnology, covering technologies such as messenger RNA and recombinant proteins.<\/p>\n

The company continues to accelerate its global expansion, consolidating its presence in Latin America, Asia, Africa and Europe, and reaching more than 200 new approved registrations last year. \u201cThis sustained growth drives the planning of a fourth plant, aimed at meeting the growing demand for quality products worldwide,\u201d added Roo.<\/p>\n

Thanks to its strategic alliance with Genneia, 80% of energy resources comes from renewable sources, making it the first Argentine veterinary laboratory to achieve this significant accomplishment.<\/p>\n

In the field of innovation, the laboratory is developing vaccines across several species, including Equine Encephalomyelitis and others for pigs and pets, achieving significant breakthroughs in each of these lines.<\/p>\n

On the occasion of its 40th anniversary in 2025, the company is expecting 26% growth, while it aims to self-position among the top 20 veterinary laboratories worldwide in the coming years.<\/p>\n

The recent achievement reinforces leadership, highlighting its contribution to livestock productivity and a safe and sustainable food system. \u201cWe are proud to maintain this recognition in Argentina, since it reflects our human capital talent, professional excellence, and the development of cutting-edge technology,” concluded CDV executive.<\/p>\n

Further to this award, the company emphatically dedicated it to all their staff, clients, veterinarians, producers, institutions and anyone working to improve production.<\/p>\n

About CDV:
\nCDV is a leading Argentine laboratory specialized in the production of vaccines for the prevention of diseases that affect cattle and sheep herds, with 40 years of experience in Argentina. Their prevention-oriented line of products and services is the most complete line on the market, including vaccines against viruses and bacteria, vaccination for foot-and-mouth disease, reagents and diagnostic service. Innovating in the production of aquaculture vaccines since 2002. CDV laboratory was distinguished as the \u201cBest company in the Veterinary Sector in Latin America\u201d by the British magazine Animal Health in 2019 and 2023. CDV exports their products to more than 20 countries.<\/p>\n

It owns two modern vaccine production plants, and a third one is under construction, all of them located in the Pilar Industrial Park, province of Buenos Aires:
\nPlant 1: since 2003 we have been producing vaccines for the prevention of reproductive, respiratory, clostridial diseases, keratoconjunctivitis, enteric neonatal complex and preventive of important zoonotic diseases such as Brucellosis, Rabies, Carbuncle and Leptospirosis. Aso a diagnostic reagents producer for the detection of Tuberculosis and Brucellosis as well as vaccines to prevent diseases in birds and salmonids. The same premises host a Diagnostic Laboratory of the SENASA network. Annual total production capacity of 150MM doses, out of which 85 million doses go to bovine vaccines and the rest to salmonids and birds.
\nPlant 2: exclusively allocated to FMD (Aftosa) vaccine production since 2018. This Plant includes state-of-the-art equipment and a high degree of system automation to ensure compliance with the most demanding quality and biosafety standards worldwide. With a productive capacity of over 60MM doses of foot-and-mouth vaccine.
\nPlant 3: currently under construction and estimated to be operational during the first half of 2025. The productive capacity of Plant 1 will be enhanced and products for animal health and disease prevention in new species will be produced: vaccines for pets, companion animals and pigs. The total projected production capacity will reach – together with the production of plant 1- 280MM doses, out of which 190MM go to bovine vaccines. Follow the work in progress on livestreaming: https:\/\/cdv.com.ar\/live\/[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

[vc_row woodmart_css_id=”67aca7bfb9514″ responsive_spacing=”eyJwYXJhbV90eXBlIjoid29vZG1hcnRfcmVzcG9uc2l2ZV9zcGFjaW5nIiwic2VsZWN0b3JfaWQiOiI2N2FjYTdiZmI5NTE0Iiwic2hvcnRjb2RlIjoidmNfcm93IiwiZGF0YSI6eyJ0YWJsZXQiOnt9LCJtb2JpbGUiOnt9fX0=” mobile_bg_img_hidden=”no” tablet_bg_img_hidden=”no” woodmart_parallax=”0″ woodmart_gradient_switch=”no” woodmart_box_shadow=”no” wd_z_index=”no” woodmart_disable_overflow=”0″ row_reverse_mobile=”0″ row_reverse_tablet=”0″][vc_column width=”1\/2″][\/vc_column][vc_column width=”1\/2″][vc_column_text css=”” woodmart_inline=”no” text_larger=”no”]A CDV recebeu o<\/p>\n","protected":false},"author":2,"featured_media":11034,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[166],"tags":[173],"class_list":["post-10996","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog","tag-institutional"],"_links":{"self":[{"href":"https:\/\/cdv.com.ar\/global\/pt\/wp-json\/wp\/v2\/posts\/10996","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cdv.com.ar\/global\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cdv.com.ar\/global\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cdv.com.ar\/global\/pt\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/cdv.com.ar\/global\/pt\/wp-json\/wp\/v2\/comments?post=10996"}],"version-history":[{"count":7,"href":"https:\/\/cdv.com.ar\/global\/pt\/wp-json\/wp\/v2\/posts\/10996\/revisions"}],"predecessor-version":[{"id":11284,"href":"https:\/\/cdv.com.ar\/global\/pt\/wp-json\/wp\/v2\/posts\/10996\/revisions\/11284"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cdv.com.ar\/global\/pt\/wp-json\/wp\/v2\/media\/11034"}],"wp:attachment":[{"href":"https:\/\/cdv.com.ar\/global\/pt\/wp-json\/wp\/v2\/media?parent=10996"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cdv.com.ar\/global\/pt\/wp-json\/wp\/v2\/categories?post=10996"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cdv.com.ar\/global\/pt\/wp-json\/wp\/v2\/tags?post=10996"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}